Track the Citi Pharma Ltd. stock price and the full management transaction log of the company, a listed issuer based in Pakistan. Shares are quoted on the PK market, under the oversight of PSX (SECP). Market capitalisation: €436.2bn. The latest transaction was disclosed on 10 August 2026. The full history is free.
31
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Citi Pharma Ltd. Strong Buy (bullish), based on 10 analysts. Average price target: CN¥38.13.
Fundamental score
Ranked 671 of 28,896 companies
83.3
score / 100
Value
84
Quality
83
FCF yld17%
Earn yld6.9%
EV/EBITDA·
ROE12%
Gross mgn·
Net mgn40%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.